Current Cancer Drug Targets
Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
  |
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Current Cancer Drug Targets, Volume 14 - Number 9
Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
, 14(9): 775 - 793Deepa Subramaniam, Aiwu R. He, Jimmy Hwang, John Deeken, Michael Pishvaian, Marion L. Hartley and John L. Marshall
DOI: 10.2174/1568009614666141111104643
Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
, 14(9): 794 - 816Roman Mezencev
DOI: 10.2174/1568009614666141128105146
Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
LAT1 Targeted Delivery of Methionine Based Imaging Probe Derived from M(III) Metal Ions for Early Diagnosis of Proliferating Tumours using Molecular Imaging Modalities
, 14(9): 817 - 831Puja P. Hazari, Surbhi Prakash, Virendra K. Meena, Ambika Jaswal, Harleen Khurana, Surabhi K. Mishra, Hemanth kumar Somu Bhonsle, Lokendra Singh and Anil K. Mishra
DOI: 10.2174/1568009614666141020102337
LAT1 Targeted Delivery of Methionine Based Imaging Probe Derived from M(III) Metal Ions for Early Diagnosis of Proliferating Tumours using Molecular Imaging Modalities
Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
, 14(9): 832 - 849Sara Horta, Ana L. Agostinho, Rita Mateus, Lucilia Pereira, Carolina Pereira, Liliana Capinha, Slavomira Doktorovova, Alexandra Brito and Mafalda Videira
DOI: 10.2174/1568009614666141111154713
Looking out for Cancer Stem Cells’ Properties: The Value-Driving Role of CD44 for Personalized Medicines
TXNL1 Induces Apoptosis in Cisplatin Resistant Human Gastric Cancer Cell Lines
, 14(9): 850 - 859Pan Ni, Wenxia Xu, Yajie Zhang, Qi Chen, Aiping Li, Shouyu Wang, Shan Xu and Jianwei Zhou
DOI: 10.2174/1568009614666141028094612
TXNL1 Induces Apoptosis in Cisplatin Resistant Human Gastric Cancer Cell Lines
Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
, 14(9): 860 - 871Rui Zhou, Zongliang Lu, Kai Liu, Jing Guo, Jie Liu, Yong Zhou, Jian Yang, Mantian Mi and Hongxia Xu
DOI: 10.2174/1568009614666141128104642
Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75
Advertisement
Webmaster Contact: info@benthamscience.net